Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | VNN1 | O95497 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | GLS | O94925 | 1/20 | 0.39 |
| ▸ | MAOB | P27338 | 2/20 | 0.39 |
| ▸ | PARP15 | Q460N3 | 1/20 | 0.39 |
| ▸ | PARP14 | Q460N5 | 1/20 | 0.39 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.39 |
| ▸ | CASP3 | P42574 | 1/20 | 0.38 |
| ▸ | CASP7 | P55210 | 1/20 | 0.38 |
| ▸ | CXCL8 | P10145 | 2/20 | 0.38 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2717117 | 0.83 | VNN1 (0.45) | VNN1ALDH1A1MAPK1MEN1KMT2A | |
| SCHEMBL1538027 | 0.83 | VNN1 (0.48) | VNN1ALDH1A1MAPK1MEN1KMT2A | |
| SCHEMBL3013122 | 0.82 | ALDH1A1 (0.46) | VNN1ALDH1A1MAPK1MEN1KMT2A | |
| SCHEMBL4661911 | 0.81 | ALDH1A1 (0.51) | VNN1ALDH1A1MAPK1MEN1KMT2A | |
| SCHEMBL6225369 | 0.81 | CTBP2 (0.47) | ALDH1A1KMT2AMAPK8RAB9AGLS | |
| SCHEMBL6222569 | 0.79 | MAPK8 (0.40) | ALDH1A1KMT2AMAPK8LMNARAB9A | |
| SCHEMBL8204011 | 0.79 | VNN1 (0.45) | VNN1ALDH1A1MAPK1MEN1KMT2A | |
| SCHEMBL8677157 | 0.79 | VNN1 (0.50) | VNN1ALDH1A1MAPK1MEN1KMT2A | |
| SCHEMBL11078708 | 0.76 | MMP2 (0.37) | VNN1 | |
| Methylene Chloride SCHEMBL28534416 | 0.74 | ALDH1A1 (0.48) | ALDH1A1MAPK1MEN1KMT2AMAPK8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2123656-B1 | PROCESS FOR PRODUCTION OF PRASUGREL HYDROCHLORIDE HAVING HIGH PURITY | DAIICHI SANKYO CO LTD (JP) | 2014-06-11 | — | — | EP | disclosed |
| US-20130345428-A1 | METHOD FOR PRODUCTION OF PRASUGREL HYDROCHLORIDE HAVING HIGH PURITY | UBE INDUSTRIES, LTD. (JP) | 2013-12-26 | — | — | US | disclosed |
| WO-2012052788-A1 | METHOD FOR PREPARING PHARMACEUTICALLY ACTIVE INGREDIENT AND INTERMEDIATES THEREOF | EGIS GYÓGYSZERGYÁR NYILVÁNOSAN MŰKÖDŐ RÉSZVÉNYTÁRSASÁG (HU) | 2012-04-26 | — | — | WO | disclosed |
| US-20100094013-A1 | PROCESS FOR PRODUCTION OF PRASUGREL HYDROCHLORIDE HAVING HIGH PURITY | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2010-04-15 | — | — | US | disclosed |
| EP-2123656-A1 | PROCESS FOR PRODUCTION OF PRASUGREL HYDROCHLORIDE HAVING HIGH PURITY | Daiichi Sankyo Company, Limited (JP) | 2009-11-25 | — | — | EP | disclosed |
| EP-1411942-A4 | SUBSTITUTED ANILINIC PIPERIDINES AS MCH SELECTIVE ANTAGONISTS | SYNAPTIC PHARMA CORP (US) | 2005-01-26 | — | — | EP | disclosed |
| EP-1411942-A1 | SUBSTITUTED ANILINIC PIPERIDINES AS MCH SELECTIVE ANTAGONISTS | Synaptic Pharmaceutical Corporation (US) | 2004-04-28 | — | — | EP | disclosed |
| WO-2003004027-A1 | SUBSTITUTED ANILINIC PIPERIDINES AS MCH SELECTIVE ANTAGONISTS | SYNAPTIC PHARMACEUTICAL CORPORATION (US) | 2003-01-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100094013-A1 | PROCESS FOR PRODUCTION OF PRASUGREL HYDROCHLORIDE HAVING HIGH PURITY | AGPS, CAT, PFKP | VNN1 2176/4885ALDH1A1 435/4885MAPK1 3172/4885 |
| US-20130345428-A1 | METHOD FOR PRODUCTION OF PRASUGREL HYDROCHLORIDE HAVING HIGH PURITY | PFKP, PF4, POR | VNN1 1509/4885ALDH1A1 476/4885MAPK1 2179/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.